Metabolic kinetics of glyceraldehyde and investigation of the relationship between glyceraldehyde and liver steatosis in patients with diabetes.

Metabolic kinetics of glyceraldehyde and investigation of the relationship between glyceraldehyde and liver steatosis in patients with diabetes. - Metabolic kinetics of glyceraldehyde and investigation of the relationship between glyceraldehyde and liver steatosis in patients with diabetes.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054118

Enrollment

Registered

2024-04-12

Start date

2024-04-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type2 diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type2 diabetes patients over 18 years old

Exclusion criteria

Exclusion criteria: severe kidney dysfunction (eGFR under 30ml/min/1.73m2) use of steroid pregnant or breast-feeding

Design outcomes

Primary

Measure	Time frame
Glyceraldehyde levels before and after treatment of hyperglycemia	—

Secondary

Measure	Time frame
Hepatic fat content before and after hyperglycemia treatment Liver stiffness before and after hyperglycemia treatment Visceral fat area before and after hyperglycemia treatment Serum liver enzyme levels and fibrosis markers before and after hyperglycemia treatment Plasma glyceraldehyde levels and hepatic fat content	—

Countries

Japan

Contacts

Public ContactYoko Ueba

Graduate School of Medicine, Kyoto University Department of Diabetes, Endocrinology and Nutrition

yokoueba@kuhp.kyoto-u.ac.jp075-751-3560

Outcome results